Editorial: JAK to JAK-Navigating Intra-Class JAK Inhibitor Switching in Inflammatory Bowel Disease. Authors' Reply. Uzzan M, Laharie D, Kirchgesner J. Aliment Pharmacol Ther 2025;62:460-461.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Uzzan M, Laharie D, Kirchgesner J. Editorial: JAK to JAK-Navigating Intra-Class JAK Inhibitor Switching in Inflammatory Bowel Disease. Authors' Reply. Aliment Pharmacol Ther 2025;62:460-461.
PMID: 40682429